Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.
Scand J Rheumatol
; 49(1): 33-37, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31161842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antigens, Differentiation, Myelomonocytic
/
Cardiovascular Diseases
/
Carotid Arteries
/
Antigens, CD
/
Receptors, Cell Surface
/
Plaque, Atherosclerotic
/
Lupus Erythematosus, Systemic
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Scand J Rheumatol
Year:
2020
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido